SCHEMBL21323359

SCHEMBL21323359

O=C(/C=C/c1ccc(C(F)(F)F)cn1)N1CC2CN(C(=O)c3ccc4[nH]nnc4c3)CC2C1

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ATXN2 Q99700 1/20 0.41
▸ SCN9A Q15858 9/20 0.38
▸ GPR183 P32249 3/20 0.38
▸ HCRTR1 O43613 2/20 0.36
▸ HCRTR2 O43614 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ ENPP2 Q13822 1/20 0.36
▸ DGAT2 Q96PD7 1/20 0.36
▸ HPGD P15428 1/20 0.35
▸ SCN10A Q9Y5Y9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16962996 1.00 ATXN2 (0.41) ATXN2SCN9AGPR183HCRTR1HCRTR2
SCHEMBL16962999 1.00 ATXN2 (0.41) ATXN2SCN9AGPR183HCRTR1HCRTR2
SCHEMBL21323334 0.88 GPR183 (0.49) ATXN2GPR183ENPP2DGAT2
SCHEMBL16963560 0.88 GPR183 (0.49) ATXN2GPR183ENPP2DGAT2
SCHEMBL16963565 0.88 GPR183 (0.49) ATXN2GPR183ENPP2DGAT2
SCHEMBL21313886 0.86 GPR183 (0.34) ATXN2SCN9AGPR183ALDH1A1LMNA
SCHEMBL16962997 0.86 GPR183 (0.34) ATXN2SCN9AGPR183ALDH1A1LMNA
SCHEMBL16963203 0.84 HTR2B (0.39) ATXN2HPGD
SCHEMBL16963201 0.84 HTR2B (0.39) ATXN2HPGD
SCHEMBL21323309 0.83 GPR183 (0.39) ATXN2GPR183ENPP2DGAT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2900669-B1 HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AND RELATED COMPOUNDS AS AUTOTAXIN (ATX) INHIBITORS AND AS INHIBITORS OF THE LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION FOR TREATING E.G. RENAL DISEASES HOFFMANN LA ROCHE (CH) 2019-09-04 — — EP disclosed
Send feedback